What is already known about this topic? Poor adherence to asthma and chronic obstructive pulmonary disease medications is commonplace despite the known risks for adverse health outcomes and associated consumption of costly health care resources.

What does this article add to our knowledge? Implementing programs to improve adherence to inhaled medicines can be cost-effective, reducing medical costs and consumption of health care resources and improving disease control and patient-reported outcomes.

How does this study impact current management guidelines? Implementation of proven adherence promotion programs (eg, using digitally enhanced care and one-to-one counseling) is cost-effective and could help improve asthma and chronic obstructive pulmonary disease control and aid management of health care budgets.

https://www.jaci-inpractice.org/article/S2213-2198(24)00006-0/fulltext